Discover trends, market shifts, and competitive outlooks for the circulating tumor cells industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Projections for the CAGR of the Circulating Tumor Cells Market Size From 2025 to 2034?

In recent times, we’ve seen a speedy expansion in the circulating tumor cells market size. The market, that was valued at $11.9 billion in 2024, is expected to surge to $13.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.4%. The prompt growth witnessed during the historic period can be linked to various factors such as the increasing occurrence of cancer, its rising prevalence, utility in cancer staging, the emergence of liquid biopsy, the incline of patients towards minimally invasive tests, strong regulatory support for liquid biopsies, and an increased emphasis on early detection of cancer.

The market size of circulating tumor cells is predicted to experience swift expansion in the coming years, escalating to $21.68 billion in 2029 with a compound annual growth rate (CAGR) of 12.8%. The predicted increase during the forecast period is due to factors such as point-of-care CTC examinations, incorporation of microfluidics, concentration on unusual cancer varieties, standardization of CTC tests, growth of clinical trials based on CTC, and economic growth in emerging markets. Noteworthy trends during the forecast period include advancements in techniques for isolating CTC, government financial support for CTC research, advancements in the technology used for detecting CTC, liquid biopsy for monitoring cancer, integration with individual cell analysis, and technological merger with artificial intelligence (AI).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Are the Core Growth Drivers Propelling the Circulating Tumor Cells Market Forward?

The anticipated growth of the circulating tumor cells market is linked to the rising prevalence of cancer. Cancer is described as a condition where some bodily cells proliferate uncontrollably and disseminate to other sections. Circulating tumor cells aid in the early identification and diagnosis of this disease, making the escalation of cancer a contributing factor to the market’s expansion. For example, the American Cancer Society Journals, a volunteer health organization based in the U.S., forecasted in January 2023 that there would be 1,958,310 new instances of cancer diagnosed and 609,820 cancer-related fatalities in the U.S. Hence, the increasing cancer incidence is propelling the circulating tumor cells market’s growth.

What Segment Types Define the Circulating Tumor Cells Market Structure?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing theCirculating Tumor Cells Industry Evolution?

One significant trend emerging in the circulating tumor cells market is the emphasis on product innovation. Major industry players are concentrating on the development of unique products to cement their market position. For example, in June 2024, Bio-Rad Laboratories, Inc., a medical lab based in the U.S., released Celselect Slides 2.0. This product is built to improve the collection of rare cells and circulating tumor cells (CTCs), thereby boosting the precision and effectiveness of cell analysis in clinical and research settings.

View the full report here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

What Is the Definition of the Circulating Tumor Cells Market?

Circulating tumor cells refer to solid tumor-derived cells that have shed from the primary tumor and are extravasated into the blood circulation system. They are used as a tool to diagnose and prognosis of cancer.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model